Jan 29, 2021 / 02:00PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to the Catabasis Pharmaceuticals Corporate conference call. (Operator Instructions)
I would now like to turn the conference over to your host, Andrea Matthews, Senior Vice President in Corporate Affairs. Please go ahead.
Andrea L. Matthews - Catabasis Pharmaceuticals, Inc. - SVP of Corporate Affairs
Thank you. Good morning, everyone, and welcome to today's Catabasis Pharmaceuticals conference call.
Earlier today, we issued a press release that outlined our acquisition of Quellis Biosciences and a private placement financing. This release is available on our website in the Investors section.
As outlined on Slide 2, I would like to note that during today's call, we will make statements related to our business based on current and future expectations that may be considered forward-looking statements under federal securities laws. Actual results may differ materially from those indicated by these statements as a result of a variety of risks and uncertainties, including those discussed in
Catabasis Pharmaceuticals Inc Acquisition of Quellis Biosciences Inc Call Transcript
Jan 29, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers